Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Sigilon

<< Previous

Bullboard Posts

Next >>

Comment by MoneyMouthon Mar 25, 2021 10:08am

208 Views

Post# 32874583

RE:RE:RE:RE:RE:Sigilon

I think WK made a good point when he said this company is sort of immune to grumbly old angry investors, because if the pouch works then the pouch works and all those pissed off investors who were angry by a reverse split and left will come running to get back in. Given the context, I can see a reverse split having a lessened impact than what we aee historically with other companies. At the same time though, SVA won't need to do a reverse split after news starts flowing

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario